Enclomiphene DirectEnclomiphene

Enclomiphene Direct / Safety

Enclomiphene drug interactions: what actually matters

Last updated 2026-07-27

TL;DR

Enclomiphene has no large formal drug-interaction database because it's compounded, not FDA-approved. The known concerns come from clomiphene data: anticoagulant effects, other SERMs or aromatase inhibitors, and drugs affecting liver enzymes (CYP2D6, CYP3A4). Tell your prescriber about every medication and supplement you take, especially blood thinners, other hormone therapies, and seizure medications.

What is enclomiphene and why does its interaction profile matter?

Enclomiphene is one of two isomers that make up clomiphene citrate, the older fertility drug. It's the trans-isomer, the one that does most of the estrogen-blocking work at the hypothalamus and pituitary. That action tells your brain to make more LH and FSH, which in turn tells your testicles to make more testosterone, on their own. That's the whole pitch: testosterone goes up because your body makes it, not because you're injecting it. This matters for interactions because enclomiphene isn't sitting in a big FDA post-marketing database the way testosterone cypionate or metformin is. The manufacturer that tried to bring enclomiphene to market as a standalone drug, under the brand name Androxal, never got FDA approval. Repros Therapeutics ran Phase 3 trials in the early 2010s and the program stalled out. What men buy today from compounding pharmacies is not an FDA-approved product [1]. That means there's no FDA-reviewed prescribing label with an official drug interactions section for enclomiphene itself. So the interaction data we have comes from two places: the older clomiphene citrate literature (enclomiphene is half of that molecule) and basic pharmacology reasoning about what a SERM does in the body. Neither is as strong as a real Phase 3 safety database. Worth saying plainly. For background on how strong that human evidence actually is, see Enclomiphene Direct human studies.

Does enclomiphene interact with blood thinners like warfarin?

This is the interaction with the most actual clinical documentation, though it comes from clomiphene, not enclomiphene specifically. Clomiphene citrate's FDA-approved labeling history includes cautions around use with anticoagulants, largely because estrogen-modulating compounds can shift clotting factor levels and, separately, because clomiphene use itself carries a rare but recognized association with thromboembolic events [2]. If you're on warfarin, a DOAC (apixaban, rivaroxaban), or even long-term aspirin for a cardiac history, your prescriber needs to know before you start enclomiphene. This isn't a reason to panic. It's a reason to make sure the person writing the prescription actually sees your full medication list, more than your testosterone number. Men with a personal or family history of blood clots, or a known clotting disorder like Factor V Leiden, are generally considered higher risk for any SERM, enclomiphene included, and that risk should be part of the conversation before starting.

Can you take enclomiphene with TRT, HCG, or other hormone therapies?

Taking enclomiphene alongside injectable or topical testosterone defeats its own purpose. Enclomiphene works by blocking estrogen's feedback signal at the hypothalamus, which raises LH and FSH, which raises your own testosterone production. If you're already putting in exogenous testosterone, your body's own feedback loop shuts down regardless of what enclomiphene is doing upstream, because the pituitary sees plenty of testosterone (and its estrogen metabolite) already circulating. Stacking the two doesn't make sense pharmacologically and isn't a standard combination protocol. HCG is a different story. HCG mimics LH directly at the testicle, so it works downstream of where enclomiphene works (upstream, at the brain). Some fertility-focused protocols combine SERMs with HCG, but that's a decision for a reproductive endocrinologist managing a specific fertility case, not a default stack. If you're curious how the two compare as fertility-preserving options on their own, see Enclomiphene Direct vs hcg. Combining enclomiphene with an aromatase inhibitor (anastrozole, letrozole) is common in some off-label protocols aimed at controlling estradiol, but the two drugs work through different mechanisms and stacking them adds interaction complexity: both affect the same hormonal feedback loop, and estradiol suppression that's too aggressive can hurt lipids, bone density, and libido. This should be lab-guided, not guessed at.

Does enclomiphene interact with other SERMs like tamoxifen or clomiphene?

Taking enclomiphene with tamoxifen, raloxifene, or clomiphene citrate itself is redundant at best and confusing to interpret at worst. All of these are selective estrogen receptor modulators. They compete for the same estrogen receptor binding sites. Layering them doesn't add benefit and makes it much harder to know which drug is responsible for any side effect or lab change you see. Remember that clomiphene citrate actually contains enclomiphene already (it's a roughly 62:38 mixture of enclomiphene and zuclomiphene, the two isomers of the same base molecule) [3]. So taking clomiphene and calling it "enclomiphene" separately is a labeling confusion, not a real combination. Nobody should be prescribed both under different names without their prescriber realizing they're the same base compound. Zuclomiphene, the isomer left out of enclomiphene, has a longer half-life and weaker estrogen-blocking action, and some researchers think it contributes to the mood-related side effects more associated with clomiphene use. That's part of the reasoning behind isolating enclomiphene in the first place, though the isolated-isomer approach never reached full FDA approval on its own.

What about liver enzyme interactions (CYP2D6, CYP3A4 drugs)?

Clomiphene is metabolized in the liver, largely through cytochrome P450 pathways including CYP3A4 and, to a lesser extent, other CYP enzymes. Enclomiphene, as an isomer of clomiphene, is presumed to share a broadly similar metabolic pathway, though a dedicated enclomiphene-specific metabolism study in humans is thin in the public literature. Practically, that means drugs that strongly induce or inhibit CYP3A4 could theoretically change how much enclomiphene is active in your system at a given dose. Strong CYP3A4 inhibitors include ketoconazole, clarithromycin, and grapefruit juice in large quantities. Strong inducers include rifampin, carbamazepine, and St. John's Wort. None of these have been formally studied with enclomiphene specifically, so the honest answer is: nobody has run the trial. The theoretical risk exists because of shared liver enzyme pathways, not because of documented enclomiphene interaction case reports. If you're on any long-term seizure medication, an antifungal, or an HIV protease inhibitor, mention it. Your prescriber may not need to change anything, but they should know.

Enclomiphene regulatory and interaction facts at a glance Key figures behind the interaction discussion 62 Enclomiphene share of clomi… citrate mixture 38 Zuclomiphene share of clomi… citrate mixture Source: ClinicalTrials.gov, 2016; NIH StatPearls, 2023

Does enclomiphene interact with antidepressants or other mood medications?

There's no documented pharmacokinetic interaction between enclomiphene and SSRIs or SNRIs (no shared enzyme conflict that's been formally flagged). The real overlap is symptomatic, not chemical. Some men on clomiphene-family drugs report mood changes, irritability, or visual disturbances (the visual side effect, sometimes described as light trails or blurring, is one of the more distinct ones reported with clomiphene citrate in its FDA-era labeling history, though it's uncommon) [2]. If you're already managing depression or anxiety with medication, it's worth tracking mood symptoms closely in the first few weeks of enclomiphene, if only so you and your prescriber can tell what's coming from the drug and what isn't. This isn't a drug interaction in the classic sense (nothing is fighting for the same receptor), but it's a real clinical consideration your prescriber should know about before you start.

Are there interactions with supplements or over-the-counter products?

Grapefruit juice, mentioned above, is worth a real callout because it's something people don't think of as a drug. In large or consistent quantities it inhibits CYP3A4 and could theoretically raise blood levels of anything metabolized through that pathway, enclomiphene included, based on shared-pathway reasoning rather than a specific study. St. John's Wort is the opposite problem: it's a well-documented CYP3A4 inducer that lowers blood levels of many drugs metabolized that way, and it's sold over the counter as a mood supplement, so people don't always think to mention it to a prescriber [4]. Any testosterone-boosting supplement stack (a lot of over-the-counter "test boosters" contain unregulated doses of DHEA, tribulus, or actual undisclosed SERM-like compounds) should be disclosed too. Supplement labels aren't required to be accurate the way prescription drug labels are, and a stacked, undisclosed combination is exactly the scenario where something unexpected happens and nobody can figure out why.

How is enclomiphene different from testosterone therapy for interaction purposes?

MechanismBlocks estrogen feedback at hypothalamus, raises LH/FSHDirectly replaces testosterone
FDA approvalNot approved as standalone; compounded only [1]Multiple FDA-approved formulations exist
Fertility/testicular sizeGenerally preserved in available dataOften suppressed, may not fully reverse [5]
Key interaction concernAnticoagulants, other SERMs, CYP3A4 drugsErythrocytosis risk, anticoagulants
Data maturitySmall trials, some never published to full FDA reviewDecades of post-marketing dataIf you want the deeper mechanistic and study-quality comparison, Enclomiphene Direct animal studies vs human evidence walks through what's actually been tested in people versus extrapolated from animal models.

This is worth spelling out because it's the core reason men look at enclomiphene in the first place. Exogenous testosterone (injections, gels, pellets) directly replaces the hormone, which suppresses your own production through negative feedback. That suppression is well documented to reduce sperm counts and can shrink testicular volume over months of use, sometimes substantially, an effect that's reversible for many men but not guaranteed to be, especially with longer exposure [5]. Enclomiphene raises testosterone by increasing your own LH and FSH signal, which tends to preserve, rather than shut down, sperm production and testicular size, because the testicle is still getting the signal to work. This is the fertility-preservation angle that draws men to it as a TRT alternative. It's a real, mechanistically sound distinction, and it's reflected in the human trial data available so far, though those trials are still small and short relative to what we have for testosterone therapy itself . That mechanism difference means the interaction profile is different too. TRT's biggest interaction risks are around erythrocytosis (thickened blood) with anticoagulant implications, and interactions with drugs that already affect red blood cell count. Enclomiphene's interaction risks are more about estrogen receptor competition and clotting-related caution drawn from the clomiphene literature. | Factor | Enclomiphene | Injectable/topical TRT |

Why doesn't enclomiphene have an FDA drug interactions label like other medications?

Because it was never approved. That's the direct answer, and it's worth being blunt about it since it changes how you should think about every interaction claim in this article. The Androxal development program, run by Repros Therapeutics, took enclomiphene through Phase 3 trials aimed at treating secondary hypogonadism in men who wanted to preserve fertility, an alternative to standard testosterone therapy. The FDA did not approve it, and the program was discontinued [1]. No FDA-approved label exists for enclomiphene, which means there's no official, agency-reviewed drug interactions section, no boxed warning process, no formal post-marketing adverse event surveillance system tracking it under its own name the way there would be for an approved drug. What's sold today comes from compounding pharmacies, operating under different regulatory rules than manufacturers of FDA-approved drugs. Compounded medications are regulated by state pharmacy boards and, for larger-scale compounders, by FDA's compounding provisions (Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act), but they don't go through the same efficacy and safety trial process as an approved drug . That's not automatically disqualifying (compounding is legal and common for legitimate clinical reasons) but it does mean the safety and interaction data you're relying on is extrapolated, not officially reviewed. If you're deciding where to source it from, the difference between a compounding pharmacy and an unregulated "research chemical" supplier is a real distinction with real safety implications, covered in Enclomiphene Direct compounding pharmacy vs research supplier.

What should you tell your prescriber before starting enclomiphene?

Bring a full list, not a summary. Every prescription drug, every regular supplement, and anything you take occasionally but consistently (a nightly melatonin, a weekly allergy pill, a daily fish oil). Specifically flag: any blood thinner or history of blood clots, any other hormone therapy (testosterone, HCG, clomiphene under any name, an aromatase inhibitor), any seizure medication, any antifungal taken for more than a few days, and St. John's Wort if you take it. Also mention any personal or family history of vision problems, since visual disturbance is a recognized, if uncommon, effect in the clomiphene family of drugs [2]. A provider-reviewed process should ask for this list before writing anything. If a source is willing to sell enclomiphene without asking about your medications, blood pressure, or family history, that's a real signal about how seriously they're taking your safety, more than a paperwork step.

What labs or monitoring make sense once you're on enclomiphene?

Baseline labs before starting should include total and free testosterone, LH, FSH, estradiol, and a complete blood count. Repeat testosterone, estradiol, and LH/FSH around 4 to 6 weeks after starting or after any dose change is a common pattern in the small published trials, though there's no single FDA-mandated monitoring schedule since there's no approved label to mandate one . If you're on any of the interacting drug classes above, specifically anticoagulants, your prescriber may want more frequent clotting-related labs (INR if you're on warfarin) in the first few months, simply out of caution given the clomiphene-family association with thromboembolic risk. Liver function tests are reasonable if you're also on a drug with known CYP3A4 competition, given the shared metabolic pathway reasoning discussed above, even though there's no direct study proving enclomiphene causes liver enzyme changes on its own.

Frequently asked questions

Can I take enclomiphene with testosterone injections?

Not in a way that makes pharmacological sense. Enclomiphene raises your own testosterone by increasing LH and FSH signaling from the pituitary. If you're already injecting testosterone, that feedback loop is suppressed regardless, so combining the two doesn't add benefit and isn't a standard protocol most prescribers would recommend.

Does enclomiphene interact with alcohol?

There's no formally documented enclomiphene-alcohol interaction, but heavy alcohol use affects liver enzyme function generally, including the CYP pathways believed to metabolize enclomiphene, and can independently affect testosterone and estradiol levels. Moderate drinking isn't flagged as a specific concern in the available literature, but heavy or chronic use is worth mentioning to your prescriber.

Is enclomiphene safe to take with blood pressure medication?

There's no known direct interaction between enclomiphene and common blood pressure medications like ACE inhibitors, beta blockers, or calcium channel blockers. The bigger relevant factor is that testosterone changes can sometimes affect blood pressure and red blood cell count, so routine monitoring while on either therapy is reasonable regardless of the specific medication.

Can women take enclomiphene, and does that change the interaction profile?

Enclomiphene is not developed or marketed for use in women; clomiphene citrate (the full mixture including zuclomiphene) is the FDA-approved fertility drug historically used in women. The interaction concerns discussed here are drawn largely from that same clomiphene literature and would apply similarly, but this article addresses enclomiphene's use in men as a testosterone-therapy alternative specifically.

Does grapefruit juice really interact with enclomiphene?

There's no study testing grapefruit juice directly against enclomiphene. The concern is theoretical: grapefruit juice strongly inhibits CYP3A4, an enzyme believed to help metabolize enclomiphene based on its similarity to clomiphene. Large, regular grapefruit consumption could theoretically raise blood levels. It's a reasonable thing to moderate, not a proven danger.

Why isn't there an official enclomiphene drug interactions list from the FDA?

Because enclomiphene was never FDA-approved as a standalone drug. The Androxal development program by Repros Therapeutics went through Phase 3 trials but the FDA did not approve it, so no official label, and no official interactions section, exists. What's sold today is compounded medication, regulated differently than an approved drug.

Is enclomiphene the same thing as clomiphene?

No, but they're related. Clomiphene citrate is a mixture of two isomers, enclomiphene (roughly 62%) and zuclomiphene (roughly 38%). Enclomiphene is the isolated, more estrogen-blocking isomer, developed on the theory that it might cause fewer side effects than the full clomiphene mixture, though it never reached its own FDA approval.

Can enclomiphene interact with anxiety or seizure medications?

No direct pharmacokinetic interaction is documented, but some seizure medications (like carbamazepine) are CYP3A4 inducers, a pathway believed relevant to enclomiphene metabolism. This could theoretically lower enclomiphene's effective levels. Mention any seizure medication to your prescriber so they can factor it into dosing and monitoring decisions.

Does enclomiphene interact with HCG?

Not in a way that's dangerous. They work at different points in the same hormonal axis: enclomiphene acts at the hypothalamus/pituitary to raise LH and FSH, while HCG mimics LH directly at the testicle. Some fertility protocols combine them under specialist supervision, but it's a targeted clinical decision, not a routine stack.

What blood tests should I get before starting enclomiphene?

Baseline total and free testosterone, LH, FSH, estradiol, and a complete blood count are standard before starting, mirroring what's used in the small published enclomiphene trials. Repeat testing around 4 to 6 weeks after starting or after dose changes helps confirm the response and catch any estradiol or clotting-related concerns early.

Is it dangerous to combine enclomiphene with an aromatase inhibitor like anastrozole?

Not inherently dangerous, but it adds complexity. Both drugs affect the same estrogen feedback system through different mechanisms, and over-suppressing estradiol can hurt lipids, bone density, and libido. This combination should be lab-guided and prescriber-managed, not something added on your own initiative.

Why does enclomiphene preserve fertility while TRT doesn't?

TRT replaces testosterone directly, which suppresses the brain's own LH/FSH signal to the testicles, often reducing sperm production and testicular volume. Enclomiphene instead raises LH and FSH by blocking estrogen feedback at the hypothalamus, so the testicles keep getting the signal to work, which tends to preserve sperm production and size in available data, though long-term fertility outcome data is still limited.

Sources

  1. ClinicalTrials.gov, Repros Therapeutics Androxal (enclomiphene) Phase 3 program record: Enclomiphene (Androxal) went through Phase 3 trials but was not approved by the FDA as a standalone drug
  2. FDA, Clomid (clomiphene citrate) prescribing information: Clomiphene citrate labeling documents visual disturbance and thromboembolic risk considerations
  3. NIH StatPearls, Clomiphene: Clomiphene citrate is a mixture of enclomiphene (~62%) and zuclomiphene (~38%) isomers
  4. NIH StatPearls, Testosterone Replacement Therapy: Exogenous testosterone therapy suppresses endogenous LH/FSH signaling and can reduce sperm production and testicular volume
  5. Journal of Sexual Medicine, Kim et al., enclomiphene citrate trial in hypogonadal men: Enclomiphene citrate raised testosterone while maintaining LH, FSH and sperm parameters better than topical testosterone in a controlled trial